통합자연과학논문집 (Journal of Integrative Natural Science)

조선대학교 기초과학연구원 (The Basic Science Institute Chosun University)
권호 표지
DOI QR코드

DOI QR Code

In-silico analysis of Lavender oil for Non-small cell lungcancer targeting ROS1

  • Bavya Chandrasekhar (Department of Microbiology, School of Biological Science, CMS College of Science and Commerce)
  • 투고 : 2023.04.06
  • 심사 : 2023.06.19
  • 발행 : 2023.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Lavender oil is a prolonged history in ancient medicine and has a wide range of biological effects. The lavender essential oil has 50 different constituents that have different therapeutic significance. The compounds that are separated from essential oil can be used for the anticancer treatment of non-small cell lung cancer. ROS1 is one of the major targets for NSCLC. The compounds from lavender essential oil are separated through GC-MS. From 91 compounds the top compounds that are having high retention values are taken for Molecular docking study against the ROS1 target protein. The binding affinity and the docked pose for those compounds are studied. Later, the chemical reactivity of the compounds is studied by Density Functional Theory. The potent compounds must be validated by in vivo study.

키워드

참고문헌

  1. Tajuddin, A.S., Shawl, M.C., Nigam, Husain, A. "Production of lavender oil in Kashmir valley", Indian Perf., Vol. 27, No. 56.
  2. Aswal, A., Kumar, S. "Potential of Lavender oil industry in Kashmir", J. Med. Aromat. Plant Sci., Vol. 22, pp. 319-321, 2000.
  3. Singh, A.K., Sharma, A., Virmani, O.P. "Cultivation of lavender(Lavandula angustifolia Mill.) for its oil-a review", Curr. Res. Med. Arom. Plants, Vol. 6, pp. 53-63, 1983.
  4. Abbas Mardani, Maryam Maleki, Nasrin Hanifi, Yasaman Borghei, Mojtaba Vaismoradi, "A systematic review of the effect of lavender on cancer complications", ComplementaryTherapies in Medicine, Vol. 67, 2022.
  5. Shaw AT, Ou SH, Bang YJ, Camidge DR, Solomon BJ, Salgia R, Riely GJ, Varella-Garcia M, Shapiro GI, Costa DB, Doebele RC, Le LP, Zheng Z, Tan W, Stephenson P, Shreeve SM, Tye LM, Christensen JG, Wilner KD, Clark JW, Iafrate AJ. Crizotinib in ROS1-rearranged non-small-cell lung cancer. N Engl J Med, Vol. 371, No. 21, pp. 1963-71,
  6. World Health Association WHO Fact Sheet on Cancer. [(accessed on 20 October 2018)]. Available online: https://www.who.int/news-room/fact-sheets/detail/cancer
  7. D'Angelo A, Sobhani N, Chapman R, Bagby S, Bortoletti C, Traversini M, Ferrari K, Voltolini L, Darlow J, Roviello G. Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies. Cancers (Basel), Vol. 12, No. 11, p. 3293, 2020.
  8. Lin JJ, Shaw AT. Recent Advances in Targeting ROS1 in Lung Cancer. J Thorac Oncol, Vol. 12, No. 11, pp. 1611-1625, 2020. doi: 10.1016/j.jtho.2017.08.002.
  9. Gainor JF, Shaw AT. Novel targets in non-small cell lung cancer: ROS1 and RET fusions. Oncologist, Vol. 18, No. 7, pp. 865-75, 2013. doi: 10.1634/theoncologist.
  10. Shaw AT, Ou SH, Bang YJ, Camidge DR, Solomon BJ, Salgia R, Riely GJ, Varella-Garcia M, Shapiro GI, Costa DB, Doebele RC, Le LP, Zheng Z, Tan W, Stephenson P, Shreeve SM, Tye LM, Christensen JG, Wilner KD, Clark JW, Iafrate AJ. Crizotinib in ROS1-rearranged non-small-cell lung cancer. N Engl J Med, Vol. 371, No. 21, pp. 1963-71, 2014. doi: 10.1056/NEJMoa1406766.
  11. An Enhanced GC/MS Procedure for the Identification of Proteins in Paint Microsamples - D. Fico , Margapoti , Pennetta , and G. E. De Benedetto. https://doi.org/10.1155/2018/6032084
  12. Dallakyan, S. and Olson, A.J, "Small-molecule library screening by docking with PyRx", In Chemical biology., pp. 243-250, 2015.
  13. Leach, A. R, Shoichet, B. K, &Peishoff, C. E, "Prediction of protein- ligand interactions. Docking and scoring: successes and gaps", Journal of medicinal chemistry., Vol. 49, pp. 5851-5855, 2006. https://doi.org/10.1021/jm060999m
  14. Chen G, Seukep AJ, Guo M. Recent Advances in Molecular Docking for the Research and Discovery of Potential MarineDrugs. Mar Drugs, Vol. 18, No. 11, p. 545, 2020. doi: 10.3390/md18110545.
  15. Hohenberg, P.; Kohn, W. Inhomogeneous Electron Gas. Phys. Rev. 1964, 136, B864-B871. (84) Geerlings, P.; De Proft, F.; Langenaeker, W. Conceptual Density Functional Theory. Chem. Rev, Vol. 103, pp. 1793-1874, 2003. https://doi.org/10.1021/cr990029p
  16. Domingo, L. R., Rios-Gutierrez, M., and Perez, P. (2016). Applications of the Conceptual Density Functional Theory Indices to Organic Chemistry Reactivity, Molecules, Vol. 21, No. 6, p. 748. doi:10.3390/molecules21060748